UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region

Genetics (Austin), 2010-05, Vol.185 (1), p.293-303

2010

Volltextzugriff (PDF)

Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use

PloS one, 2011-07, Vol.6 (7), p.e22020-e22020

2011

Volltextzugriff (PDF)

Biology of CCR5 and its role in HIV infection and treatment

JAMA : the journal of the American Medical Association, 2006-08, Vol.296 (7), p.815

2006

Volltextzugriff (PDF)

Prevention of Vaginal SHIV Transmission in Rhesus Macaques through Inhibition of CCR5

Science (American Association for the Advancement of Science), 2004-10, Vol.306 (5695), p.485-487

2004

Volltextzugriff (PDF)

Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching

Journal of Virology, 2004-07, Vol.78 (14), p.7565-7574

2004

Volltextzugriff (PDF)

Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C

Journal of acquired immune deficiency syndromes (1999), 2011-01, Vol.56 (1), p.9-15

2011

Volltextzugriff (PDF)

Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide

Proceedings of the National Academy of Sciences - PNAS, 2008-11, Vol.105 (46), p.17706-17711

2008

Volltextzugriff (PDF)

How HIV changes its tropism: evolution and adaptation?

Current opinion in HIV & AIDS, 2009-03, Vol.4 (2), p.125

Mosier, Donald E

2009

Volltextzugriff (PDF)

Whither or Wither Microbicides?

Science (American Association for the Advancement of Science), 2008-07, Vol.321 (5888), p.532-534

2008

Volltextzugriff (PDF)

Transduction of Human CD34$^+$ Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors

Science (American Association for the Advancement of Science), 1999-01, Vol.283 (5402), p.682-686

1999

Volltextzugriff (PDF)

Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism

Journal of Virology, 2011-10, Vol.85 (20), p.10669-10681

2011

Volltextzugriff (PDF)

The Story Behind "A Requirement for Two Cell Types for Antibody Formation in vitro"

Frontiers in immunology, 2014, Vol.5, p.495-495

Mosier, Donald E

2014

Volltextzugriff (PDF)

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

Journal of Virology, 2012-09, Vol.86 (18), p.10218-10220

2012

Volltextzugriff (PDF)

HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry

AIDS (London), 2007-03, Vol.21 (6), p.693-702

2007

Volltextzugriff (PDF)

Medicinal Chemistry Applied to a Synthetic Protein: Development of Highly Potent HIV Entry Inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2004-11, Vol.101 (47), p.16460-16465

2004

Volltextzugriff (PDF)

Evolution of CCR5 Use before and during Coreceptor Switching

Journal of Virology, 2008-12, Vol.82 (23), p.11758-11766

2008

Volltextzugriff (PDF)

High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia

AIDS research and human retroviruses, 2017-03, Vol.33 (3), p.234-245

2017

Volltextzugriff (PDF)

Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo

Immunity (Cambridge, Mass.), 1999-04, Vol.10 (4), p.431-438

1999

Volltextzugriff (PDF)

Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins

Scientific reports, 2013-10, Vol.3 (1), p.3014-3014, Article 3014

2013

Volltextzugriff (PDF)

Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES

Antimicrobial Agents and Chemotherapy, 2003-02, Vol.47 (2), p.509-517

2003

Volltextzugriff (PDF)

Conserved Changes in Envelope Function during Human Immunodeficiency Virus Type 1 Coreceptor Switching

Journal of Virology, 2007-08, Vol.81 (15), p.8165-8179

2007

Volltextzugriff (PDF)

Evolution of CXCR4-Using Human Immunodeficiency Virus Type 1 SF162 Is Associated with Two Unique Envelope Mutations

Journal of Virology, 2007-04, Vol.81 (7), p.3657-3661

2007

Volltextzugriff (PDF)

CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro

Clinical immunology (Orlando, Fla.), 2003-09, Vol.108 (3), p.234-240

2003

Volltextzugriff (PDF)

"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance

Journal of virology, 2010-06, Vol.84 (11), p.5842-5845

2010

Volltextzugriff (PDF)

Changes in HIV-1 tropism: clinical and prognostic consequences

European journal of medical research, 2007-10, Vol.12 (9), p.371-374

Mosier, Donald E

2007

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(160)

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(80)
Humans
(77)
Animals
(75)
Mice
(68)
Immunology
(44)
Aids/hiv
(43)
Biological And Medical Sciences
(42)
Virology
(32)
Medical Sciences
(30)
Mice, Scid
(30)
Human Immunodeficiency Virus
(21)
Infectious Diseases
(21)
Female
(20)
Hiv-1 - Physiology
(20)
Hiv Infections - Immunology
(19)
Human Immunodeficiency Virus 1
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Hiv
(17)
Molecular Sequence Data
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region

Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use

Biology of CCR5 and its role in HIV infection and treatment

Prevention of Vaginal SHIV Transmission in Rhesus Macaques through Inhibition of CCR5

Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching

Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C

Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide

How HIV changes its tropism: evolution and adaptation?

Whither or Wither Microbicides?

Transduction of Human CD34$^+$ Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV Vectors

Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism

The Story Behind "A Requirement for Two Cell Types for Antibody Formation in vitro"

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry

Medicinal Chemistry Applied to a Synthetic Protein: Development of Highly Potent HIV Entry Inhibitors

Evolution of CCR5 Use before and during Coreceptor Switching

High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia

Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo

Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins

Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES

Conserved Changes in Envelope Function during Human Immunodeficiency Virus Type 1 Coreceptor Switching

Evolution of CXCR4-Using Human Immunodeficiency Virus Type 1 SF162 Is Associated with Two Unique Envelope Mutations

CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro

"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance

Changes in HIV-1 tropism: clinical and prognostic consequences

Suchergebnisse filtern